12-11267429-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001394862.1(PRB3):c.820G>A(p.Gly274Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000459 in 1,567,270 control chromosomes in the GnomAD database, including 24 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00027 ( 4 hom., cov: 25)
Exomes 𝑓: 0.00048 ( 20 hom. )
Consequence
PRB3
NM_001394862.1 missense
NM_001394862.1 missense
Scores
1
13
Clinical Significance
Conservation
PhyloP100: 1.37
Genes affected
PRB3 (HGNC:9339): (proline rich protein BstNI subfamily 3) This gene encodes a member of the heterogeneous family of basic, proline-rich, human salivary glycoproteins. Multiple alleles of this gene exhibiting variations in the length of the tandem repeats have been identified. The reference genome encodes the "Long" allele. The protein isoforms encoded by this gene are recognized as the "first line of oral defense" against the detrimental effects of polyphenols in the diet and pathogen infections. This gene is located in a cluster of closely related salivary proline-rich proteins on chromosome 12. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
?
Computational evidence support a benign effect (MetaRNN=0.036661386).
BS2
?
High Homozygotes in GnomAd at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRB3 | NM_001394862.1 | c.820G>A | p.Gly274Arg | missense_variant | 3/4 | ENST00000538488.3 | |
LOC107987435 | XR_007063209.1 | n.761-10041C>T | intron_variant, non_coding_transcript_variant | ||||
PRB3 | NM_006249.5 | c.694G>A | p.Gly232Arg | missense_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRB3 | ENST00000538488.3 | c.820G>A | p.Gly274Arg | missense_variant | 3/4 | 5 | NM_001394862.1 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000275 AC: 40AN: 145596Hom.: 4 Cov.: 25
GnomAD3 genomes
?
AF:
AC:
40
AN:
145596
Hom.:
Cov.:
25
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000230 AC: 57AN: 248308Hom.: 0 AF XY: 0.000230 AC XY: 31AN XY: 134654
GnomAD3 exomes
AF:
AC:
57
AN:
248308
Hom.:
AF XY:
AC XY:
31
AN XY:
134654
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000478 AC: 680AN: 1421674Hom.: 20 Cov.: 34 AF XY: 0.000453 AC XY: 319AN XY: 704758
GnomAD4 exome
AF:
AC:
680
AN:
1421674
Hom.:
Cov.:
34
AF XY:
AC XY:
319
AN XY:
704758
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.000275 AC: 40AN: 145596Hom.: 4 Cov.: 25 AF XY: 0.000339 AC XY: 24AN XY: 70782
GnomAD4 genome
?
AF:
AC:
40
AN:
145596
Hom.:
Cov.:
25
AF XY:
AC XY:
24
AN XY:
70782
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
5
ExAC
?
AF:
AC:
42
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.694G>A (p.G232R) alteration is located in exon 4 (coding exon 4) of the PRB3 gene. This alteration results from a G to A substitution at nucleotide position 694, causing the glycine (G) at amino acid position 232 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationTaster
Benign
N;N
PROVEAN
Benign
N;N
REVEL
Benign
Sift4G
Uncertain
D;T
Vest4
MutPred
Gain of catalytic residue at P228 (P = 5e-04);.;
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at